中华医学杂志（英文版）2021，Vol.134Issue(24)：3020-3022,3.DOI:10.1097/CM9.0000000000001659
Stability of trivalent human papillomavirus(types 16,18,58)recombinant vaccine(Escherichia coli)
Stability of trivalent human papillomavirus(types 16,18,58)recombinant vaccine(Escherichia coli)
Yu-Ying Liu 1Yong-Jiang Liu 2Hai-Jiang Zhang 3Er-Cui Shen 4Dan Chen 4Yan Wang 1Si-Jia Fu 1Fei Yin 1Gui-Feng Zhang 1Yi-Guo Shen1
作者信息
- 1. Quality Department of Beijing Health Guard Biotechnology Inc.,BDA,Daxing District,Beijing 100176,China
- 2. National Key Laboratory of Biochemical Engineering,Institute of Process Engineering,Chinese Academy of Sciences,Beijing 100190,China
- 3. School of Chemical and Engineering,University of Chinese Academy of Sciences,Beijing 100049,China
- 4. Research and Development Department of Beijing Health Guard Biotechnology Inc.,BDA,Daxing District,Beijing 100176,China
- 折叠
引用本文复制引用
Yu-Ying Liu,Yong-Jiang Liu,Hai-Jiang Zhang,Er-Cui Shen,Dan Chen,Yan Wang,Si-Jia Fu,Fei Yin,Gui-Feng Zhang,Yi-Guo Shen..Stability of trivalent human papillomavirus(types 16,18,58)recombinant vaccine(Escherichia coli)[J].中华医学杂志（英文版）,2021,134(24):3020-3022,3.
